Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
NEW YORK (
) -- We've got a trader's market on our hands, Jim Cramer announced on
Tuesday. That means investors can either finds stocks they like and watch them like a hawk or sell into strength and buy into weakness.
In volatile markets, investors should be used to sector gyrations and sudden shifts in direction, Cramer said. But it's still rare to see these moves occur in the same session, and that's what today's session served up for investors.
In the morning, the markets were focused on a stronger Europe and a stabilization of oil prices, along with positive news from Alcoa (AA) , Amazon.com (AMZN) and Apple (AAPL) , a stock Cramer owns for his charitable trust, Action Alerts PLUS.
Cramer said there still were come bright spots in the market. He noted that Southwest Airlines (LUV) had positive comments to combat negative ones from American Airlines (AAL) yesterday, and biotech continued to shine. But those isolated positives weren't enough to combat the overwhelming sense that things might not be as rosy as we believe.
That's why Cramer said investors can either find stocks they like and watch them closely for any fundamental changes, or trade on these wild swings, selling into strength and buying into weakness like this afternoon.
Executive Decision: Michael McNamara
For his "Executive Decision" segment, Cramer sat down with Michael McNamara, CEO of Flextronics (FLEX) , to hear about all of the latest technology stemming from this year's Consumer Electronics Show, which just finished up in Las Vegas.
McNamara said there are a lot of exciting things happening in the consumer electronics world and Flextronics is playing a part in just about all of them. He said perhaps the biggest trend right now is technology going into cars.
There's a ton of tech moving into cars, McNamara explained, from driver assist systems to make cars safer and prevent accidents to productivity tools and entertainment to make that commute more enjoyable. Everyone wins, he added.
Another big trend this year is health. McNamara said many tech companies are connecting monitoring devices right to the cloud so your doctor can monitor your health in real time.
Cramer said Flextronics remains an inexpensive stock with a lot of exciting things happening.
CEOs to Count On
Cramer said Disney's Bob Iger has been among his "bankable" CEOs for years and Cramer continues to recommend that all parents buy shares of Disney for their kids to teach them about the markets.
Under Iger's leadership, Disney has become a company built around tremendous brands, Cramer explained, brands like Pixar, Marvel and now Star Wars. Add to that the terrific franchise of ESPN and Disney's theme parks and there is massive upside, Cramer said.
Then there's Celgene, a biotech that until recently was just a one-trick pony. But under the leadership of CEO Bob Hugin, Celgene has been putting its capital to work -- broadening its portfolio to include several terrific drug prospects and franchises.
Cramer said both of these CEOs work 24/7 to make shareholders money and they're exactly the kind of CEOs investors should be adding to their portfolios.
Off the Charts
In the "Off The Charts" segment, Cramer went head to head with colleague Carly Garner over the direction of U.S. Treasuries as investors around the world continue to flock to U.S. bonds, sending interest rates ever lower.
Garner looked at the weekly chart of the iShares 20-yr Treasury ETF (TLT) , noting that bonds have rallied back to the 2012 levels, a time when the U.S. economy was in far worse shape, with heightened unemployment and a Federal Reserve actively buying bonds. She forecast a ceiling of resistance at $134 and noted the relative strength indicator, or RSI, has spiked above 70, a very bearish sign.
Garner noted a similar story when looking at a monthly chart of the Treasury ETF, noting a massively overbought situation that could fizzle very soon.
Finally, Garner noted the U.S. dollar index is also signaling a top, meaning our currency, as well as bonds, could be due for a major correction.
Cramer was bearish on Valero Energy (VLO) .
Next-Gen Biotechs: Halozyme Therapeutics
Continuing with his week-long focus on the next generation of biotech companies, Cramer spoke with Dr. Helen Torley, president and CEO of Halozyme Therapeutics (HALO) , a small-cap company that is working on treatments for diabetes and cancer, among others.
Dr. Torley said she's very optimistic about Halozyme's pancreatic cancer treatment, PEG-PH20. The treatment helps prevent sugars from forming around cancer cells, thus allowing other therapies to work better. Torrey noted that pancreatic cancer is one of the hardest to treat and physicians are constantly looking to advance the standard of care in this area.
Halozyme is also working on a new drug elvitry platform that allows more complicated drugs to be administered either at home or in clinics in far less time that traditional methods at a hospital.
Cramer said Halozyme is a very exciting company.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.
-- Written by Scott Rutt in Washington, D.C.
To email Scott about this article, click here: Scott Rutt
Follow Scott on Twitter
or get updates on Facebook,
At the time of publication, Cramer's Action Alerts PLUS had a position in AAPL, KMI and MA.